These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 26319336)

  • 41. Polymer-Free Drug-Eluting Stents: An Overview of Coating Strategies and Comparison with Polymer-Coated Drug-Eluting Stents.
    Chen W; Habraken TC; Hennink WE; Kok RJ
    Bioconjug Chem; 2015 Jul; 26(7):1277-88. PubMed ID: 26041505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
    J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First-in-man randomised comparison of a novel sirolimus-eluting stent with abluminal biodegradable polymer and thin-strut cobalt-chromium alloy: INSPIRON-I trial.
    Ribeiro EE; Campos CM; Ribeiro HB; Lopes AC; Esper RB; Meirelles GX; Perin MA; Abizaid A; Lemos PA
    EuroIntervention; 2014; 9(12):1380-4. PubMed ID: 24755382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence.
    Chisari A; Pistritto AM; Piccolo R; La Manna A; Danzi GB
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimization of cardiovascular stent against restenosis: factorial design-based statistical analysis of polymer coating conditions.
    Acharya G; Lee CH; Lee Y
    PLoS One; 2012; 7(8):e43100. PubMed ID: 22937015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deferoxamine immobilized poly(D,L-lactide) membrane via polydopamine adhesive coating: The influence on mouse embryo osteoblast precursor cells and human umbilical vein endothelial cells.
    Li H; Luo B; Wen W; Zhou C; Tian L; Ramakrishna S
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):701-709. PubMed ID: 27770944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Albumin and fibrinogen adsorption on PU-PHEMA surfaces.
    Martins MC; Wang D; Ji J; Feng L; Barbosa MA
    Biomaterials; 2003 May; 24(12):2067-76. PubMed ID: 12628827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stent.
    Xu B; Zhang Q; Yang YJ; Qiao SB; Zhang RY; Zhang JS; Hu J; Qin XW; Hong T; Li JP; Chen JL; Huo Y; Gao RL; Shen WF
    Chin Med J (Engl); 2008 Mar; 121(6):492-7. PubMed ID: 18364131
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The differential effects of poly(2-hydroxyethyl methacrylate) and poly(2-hydroxyethyl methacrylate)/poly(caprolactone) polymers on cell proliferation and collagen synthesis by human lung fibroblasts.
    Peluso G; Petillo O; Anderson JM; Ambrosio L; Nicolais L; Melone MA; Eschbach FO; Huang SJ
    J Biomed Mater Res; 1997 Mar; 34(3):327-36. PubMed ID: 9086402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biodegradable sirolimus-loaded poly(lactide) nanoparticles as drug delivery system for the prevention of in-stent restenosis in coronary stent application.
    Luderer F; Löbler M; Rohm HW; Gocke C; Kunna K; Köck K; Kroemer HK; Weitschies W; Schmitz KP; Sternberg K
    J Biomater Appl; 2011 May; 25(8):851-75. PubMed ID: 20237179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In-situ investigation of stress conditions during expansion of bare metal stents and PLLA-coated stents using the XRD sin(2)ψ-technique.
    Kowalski W; Dammer M; Bakczewitz F; Schmitz KP; Grabow N; Kessler O
    J Mech Behav Biomed Mater; 2015 Sep; 49():23-9. PubMed ID: 25974098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents.
    Xi T; Gao R; Xu B; Chen L; Luo T; Liu J; Wei Y; Zhong S
    Biomaterials; 2010 Jul; 31(19):5151-8. PubMed ID: 20382420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term clinical, angiographic, and intravascular ultrasound outcomes of biodegradable polymer-coated sirolimus-eluting stents.
    Han Y; Jing Q; Chen X; Wang S; Ma Y; Liu H; Luan B; Wang G; Li Y; Wang Z; Wang D; Xu B; Gao R
    Catheter Cardiovasc Interv; 2008 Aug; 72(2):177-83. PubMed ID: 18655114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved blood compatibility of rapamycin-eluting stent by incorporating curcumin.
    Pan CJ; Tang JJ; Shao ZY; Wang J; Huang N
    Colloids Surf B Biointerfaces; 2007 Sep; 59(1):105-11. PubMed ID: 17540543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation.
    Koppara T; Joner M; Bayer G; Steigerwald K; Diener T; Wittchow E
    Thromb Haemost; 2012 Jun; 107(6):1161-71. PubMed ID: 22535188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts.
    Steigerwald K; Merl S; Kastrati A; Wieczorek A; Vorpahl M; Mannhold R; Vogeser M; Hausleiter J; Joner M; Schömig A; Wessely R
    Biomaterials; 2009 Feb; 30(4):632-7. PubMed ID: 18990438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and evaluation of star-shaped poly(ϵ-caprolactone)-poly(2-hydroxyethyl methacrylate) as potential anticancer drug delivery carriers.
    Li C; Wang B; Liu Y; Cao J; Feng T; Chen Y; Luo X
    J Biomater Sci Polym Ed; 2013; 24(6):741-57. PubMed ID: 23565913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
    Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R;
    JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro and in vivo characterization of novel biodegradable polymers for application as drug-eluting stent coatings.
    Lockwood NA; Hergenrother RW; Patrick LM; Stucke SM; Steendam R; Pacheco E; Virmani R; Kolodgie FD; Hubbard B
    J Biomater Sci Polym Ed; 2010; 21(4):529-52. PubMed ID: 20233507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.